Around noon on Friday, March 8, 2024, Room 3073 at Stellenbosch University’s Biomedical Research Institute in South Africa was the venue for “Scientific Happy Hour,” a regular event of the Centre for Epidemic Response and Innovation.
During the session, the host, Tulio de Oliveira, who was recently named deputy director of the genomics surveillance unit at the Wellcome Sanger Institute, revealed his team adapted and successfully used their COVID-19 sequencing platform for dengue and chikungunya.
“It’s the same process and it worked. Those are the kind of things that we can learn,” de Oliveira said.